Unraveling glutamate-opioid receptor interactions using high-resolution electron microscopy: Implications for addiction-related processes

Experimental Neurology

Volumn 229, Issue 2, 2011, Pages 207-213

  Scavone, Jillian L ^a   Asan, Esther ^b   Van Bockstaele, Elisabeth J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; GLUTAMIC ACID; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OPIATE;

BEHAVIOR; BRAIN MOTIVATIONAL SYSTEM; CENTRAL NUCLEUS (AMYGDALA); EMOTION; HIGH RESOLUTION ELECTRON MICROSCOPY; HUMAN; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; NERVE CELL PLASTICITY; NEUROANATOMY; NONHUMAN; NOTE; OPIATE ADDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; SUBSTANCE ABUSE; SYNAPTIC TRANSMISSION; ULTRASTRUCTURE;

AMYGDALA; ANIMALS; MICE; MICROSCOPY, ELECTRON; RECEPTORS, AMPA; RECEPTORS, OPIOID, MU;

EID: 79956161170     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.03.016     Document Type: Note

References (96)

1. Aicher S.A., Goldberg A., Sharma S., Pickel V.M. Mu-opioid receptors are present in vagal afferents and their dendritic targets in the medial nucleus tractus solitarius. J. Comp. Neurol. 2000, 422:181-190.
2. Anderson S.M., Famous K.R., Sadri-Vakili G., Kumaresan V., Schmidt H.D., Bass C.E., Terwilliger E.F., Cha J.H., Pierce R.C. CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking. Nat. Neurosci. 2008, 11:344-353.
3. Asan E. The catecholaminergic innervation of the rat amygdala. Adv. Anat. Embryol. Cell Biol. 1998, 142:1-118.
4. Asan E., Yilmazer-Hanke D.M., Eliava M., Hantsch M., Lesch K.P., Schmitt A. The corticotropin-releasing factor (CRF)-system and monoaminergic afferents in the central amygdala: investigations in different mouse strains and comparison with the rat. Neuroscience 2005, 131:953-967.
5. Bangasser D.A., Curtis A., Reyes B.A., Bethea T.T., Parastatidis I., Ischiropoulos H., Van Bockstaele E.J., Valentino R.J. Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol. Psychiatry 2010, 15(877):896-904.
6. Beckerman M.A., Glass M.J. Ultrastructural relationship between the AMPA-GluR2 receptor subunit and the mu-opioid receptor in the mouse central nucleus of the amygdala. Exp. Neurol. 2011, 227:149-158.
7. Berrendero F., Robledo P., Trigo J.M., Martin-Garcia E., Maldonado R. Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system. Neurosci. Biobehav. Rev. 2010, 35:220-231.
8. Bie B., Peng Y., Zhang Y., Pan Z.Z. cAMP-mediated mechanisms for pain sensitization during opioid withdrawal. J. Neurosci. 2005, 25:3824-3832.
9. Bie B., Zhu W., Pan Z.Z. Ethanol-induced delta-opioid receptor modulation of glutamate synaptic transmission and conditioned place preference in central amygdala. Neuroscience 2009, 160:348-358.
10. Bie B., Zhu W., Pan Z.Z. Rewarding morphine-induced synaptic function of delta-opioid receptors on central glutamate synapses. J. Pharmacol. Exp. Ther. 2009, 329:290-296.
11. Billa S.K., Liu J., Bjorklund N.L., Sinha N., Fu Y., Shinnick-Gallagher P., Moron J.A. Increased insertion of glutamate receptor 2-lacking alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors at hippocampal synapses upon repeated morphine administration. Mol. Pharmacol. 2010, 77:874-883.
12. Brown T.H., Chapman P.F., Kairiss E.W., Keenan C.L. Long-term synaptic potentiation. Science 1988, 242:724-728.
13. Cassell M.D., Gray T.S. Morphology of peptide-immunoreactive neurons in the rat central nucleus of the amygdala. J. Comp. Neurol. 1989, 281:320-333.
14. Chen L., Huang L.Y. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a mu opioid. Neuron 1991, 7:319-326.
15. Cheng P.Y., Liu-Chen L.Y., Chen C., Pickel V.M. Immunolabeling of Mu opioid receptors in the rat nucleus of the solitary tract: extrasynaptic plasmalemmal localization and association with Leu5-enkephalin. J. Comp. Neurol. 1996, 371:522-536.
16. Commons K.G., van Bockstaele E.J., Pfaff D.W. Frequent colocalization of mu opioid and NMDA-type glutamate receptors at postsynaptic sites in periaqueductal gray neurons. J. Comp. Neurol. 1999, 408:549-559.
17. Cull-Candy S., Brickley S., Farrant M. NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol. 2001, 11:327-335.
18. Cull-Candy S., Kelly L., Farrant M. Regulation of Ca2+-permeable AMPA receptors: synaptic plasticity and beyond. Curr. Opin. Neurobiol. 2006, 16:288-297.
19. Cunha-Oliveira T., Rego A.C., Oliveira C.R. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs. Brain Res. Rev. 2008, 58:192-208.
20. Das P., Lilly S.M., Zerda R., Gunning W.T., Alvarez F.J., Tietz E.I. Increased AMPA receptor GluR1 subunit incorporation in rat hippocampal CA1 synapses during benzodiazepine withdrawal. J. Comp. Neurol. 2008, 511:832-846.
21. Das P., Zerda R., Alvarez F.J., Tietz E.I. Immunogold electron microscopic evidence of differential regulation of GluN1, GluN2A, and GluN2B, NMDA-type glutamate receptor subunits in rat hippocampal CA1 synapses during benzodiazepine withdrawal. J. Comp. Neurol. 2010, 518:4311-4328.
22. Eliava M., Yilmazer-Hanke D., Asan E. Interrelations between monoaminergic afferents and corticotropin-releasing factor-immunoreactive neurons in the rat central amygdaloid nucleus: ultrastructural evidence for dopaminergic control of amygdaloid stress systems. Histochem. Cell Biol. 2003, 120:183-197.
23. Fallon J.H., Leslie F.M. Distribution of dynorphin and enkephalin peptides in the rat brain. J. Comp. Neurol. 1986, 249:293-336.
24. Famous K.R., Kumaresan V., Sadri-Vakili G., Schmidt H.D., Mierke D.F., Cha J.H., Pierce R.C. Phosphorylation-dependent trafficking of GluR2-containing AMPA receptors in the nucleus accumbens plays a critical role in the reinstatement of cocaine seeking. J. Neurosci. 2008, 28:11061-11070.
25. Famous K.R., Schmidt H.D., Pierce R.C. When administered into the nucleus accumbens core or shell, the NMDA receptor antagonist AP-5 reinstates cocaine-seeking behavior in the rat. Neurosci. Lett. 2007, 420:169-173.
26. Farb C.R., Aoki C., Ledoux J.E. Differential localization of NMDA and AMPA receptor subunits in the lateral and basal nuclei of the amygdala: a light and electron microscopic study. J. Comp. Neurol. 1995, 362:86-108.
27. Fitzgerald L.W., Ortiz J., Hamedani A.G., Nestler E.J. Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J. Neurosci. 1996, 16:274-282.
28. Ghasemzadeh M.B., Vasudevan P., Mueller C. Locomotor sensitization to cocaine is associated with distinct pattern of glutamate receptor trafficking to the postsynaptic density in prefrontal cortex: early versus late withdrawal effects. Pharmacol. Biochem. Behav. 2009, 92:383-392.
29. Ghasemzadeh M.B., Vasudevan P., Mueller C., Seubert C., Mantsch J.R. Region specific alterations in glutamate receptor expression and subcellular distribution following extinction of cocaine self-administration 2009, Brain Res.
30. Giacchino J.L., Henriksen S.J. Opioid effects on activation of neurons in the medial prefrontal cortex. Prog. Neuropsychopharmacol. Biol. Psychiatry 1998, 22:1157-1178.
31. Glass M.J. The role of functional postsynaptic NMDA receptors in the central nucleus of the amygdala in opioid dependence. Vitam. Horm. 2010, 82:145-166.
32. Glass M.J., Kruzich P.J., Colago E.E., Kreek M.J., Pickel V.M. Increased AMPA GluR1 receptor subunit labeling on the plasma membrane of dendrites in the basolateral amygdala of rats self-administering morphine. Synapse 2005, 58:1-12.
33. Glass M.J., Kruzich P.J., Kreek M.J., Pickel V.M. Decreased plasma membrane targeting of NMDA-NR1 receptor subunit in dendrites of medial nucleus tractus solitarius neurons in rats self-administering morphine. Synapse 2004, 53:191-201.
34. Glass M.J., Lane D.A., Colago E.E., Chan J., Schlussman S.D., Zhou Y., Kreek M.J., Pickel V.M. Chronic administration of morphine is associated with a decrease in surface AMPA GluR1 receptor subunit in dopamine D1 receptor expressing neurons in the shell and non-D1 receptor expressing neurons in the core of the rat nucleus accumbens. Exp. Neurol. 2008, 210:750-761.
35. Glass M.J., Vanyo L., Quimson L., Pickel V.M. Ultrastructural relationship between N-methyl-D-aspartate-NR1 receptor subunit and mu-opioid receptor in the mouse central nucleus of the amygdala. Neuroscience 2009, 163:857-867.
36. Good C.H., Lupica C.R. Afferent-specific AMPA receptor subunit composition and regulation of synaptic plasticity in midbrain dopamine neurons by abused drugs. J. Neurosci. 2010, 30:7900-7909.
37. Gracy K.N., Svingos A.L., Pickel V.M. Dual ultrastructural localization of mu-opioid receptors and NMDA-type glutamate receptors in the shell of the rat nucleus accumbens. J. Neurosci. 1997, 17:4839-4848.
38. Groc L., Choquet D. AMPA and NMDA glutamate receptor trafficking: multiple roads for reaching and leaving the synapse. Cell Tissue Res. 2006, 326:423-438.
39. Groc L., Heine M., Cognet L., Brickley K., Stephenson F.A., Lounis B., Choquet D. Differential activity-dependent regulation of the lateral mobilities of AMPA and NMDA receptors. Nat. Neurosci. 2004, 7:695-696.
40. Hearing M.C., Schwendt M., McGinty J.F. Suppression of activity-regulated cytoskeleton-associated gene expression in the dorsal striatum attenuates extinction of cocaine-seeking. Int. J. Neuropsychopharmacol. 2010, 1-12.
41. Huang J., Wang H., Pickel V.M. Rostrocaudal variation in targeting of N-methyl-D-aspartate and mu-opioid receptors in the rat medial nucleus of the solitary tract. J. Comp. Neurol. 2000, 421:400-411.
42. Ishida S., Shimosaka R., Kawasaki Y., Jin C., Kitamura Y., Araki H., Sendo T., Gomita Y. Involvement of the amygdala on place aversion induced by naloxone in single-dose morphine-treated rats. Yakugaku Zasshi 2008, 128:395-403.
43. Jaferi A., Pickel V.M. Mu-opioid and corticotropin-releasing-factor receptors show largely postsynaptic co-expression, and separate presynaptic distributions, in the mouse central amygdala and bed nucleus of the stria terminalis. Neuroscience 2009, 159:526-539.
44. Jonas P., Sakmann B. Glutamate receptor channels in isolated patches from CA1 and CA3 pyramidal cells of rat hippocampal slices. J. Physiol. 1992, 455:143-171.
45. Kalivas P.W., Lalumiere R.T., Knackstedt L., Shen H. Glutamate transmission in addiction. Neuropharmacology 2009, 56(Suppl 1):169-173.
46. Kalivas P.W., Peters J., Knackstedt L. Animal models and brain circuits in drug addiction. Mol. Interv. 2006, 6:339-344.
47. Kessels H.W., Malinow R. Synaptic AMPA receptor plasticity and behavior. Neuron 2009, 61:340-350.
48. Knackstedt L.A., Kalivas P.W. Glutamate and reinstatement. Curr. Opin. Pharmacol. 2009, 9:59-64.
49. Koob G.F. Neuroadaptive mechanisms of addiction: studies on the extended amygdala. Eur. Neuropsychopharmacol. 2003, 13:442-452.
50. Koob G.F. Hedonic homeostatic dysregulation as a driver of drug-seeking behavior. Drug Discov. Today Dis. Models 2008, 5:207-215.
51. Koob G.F. A role for brain stress systems in addiction. Neuron 2008, 59:11-34.
52. Kumaresan V., Yuan M., Yee J., Famous K.R., Anderson S.M., Schmidt H.D., Pierce R.C. Metabotropic glutamate receptor 5 (mGluR5) antagonists attenuate cocaine priming- and cue-induced reinstatement of cocaine seeking. Behav. Brain Res. 2009, 202:238-244.
53. Lane D.A., Lessard A.A., Chan J., Colago E.E., Zhou Y., Schlussman S.D., Kreek M.J., Pickel V.M. Region-specific changes in the subcellular distribution of AMPA receptor GluR1 subunit in the rat ventral tegmental area after acute or chronic morphine administration. J. Neurosci. 2008, 28:9670-9681.
54. Lang P.J., Davis M. Emotion, motivation, and the brain: reflex foundations in animal and human research. Prog. Brain Res. 2006, 156:3-29.
55. Leranth C., Pickel V.M. Electron microscopic preembedding double-immunostaining methods. Neuroanatomical tract tracing methods 2: recent progress 1989, 129-172. Plenum Press, New York. L. Heimer, L. Záborszky (Eds.).
56. Li Y., He L., Chen Q., Zhou Y. Changes of micro-opioid receptors and GABA in visual cortex of chronic morphine treated rats. Neurosci. Lett. 2007, 428:11-16.
57. Lopez de Armentia M., Sah P. Development and subunit composition of synaptic NMDA receptors in the amygdala: NR2B synapses in the adult central amygdala. J. Neurosci. 2003, 23:6876-6883.
58. Lujan R., Nusser Z., Roberts J.D., Shigemoto R., Somogyi P. Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus. Eur. J. Neurosci. 1996, 8:1488-1500.
59. Mansour A., Fox C.A., Burke S., Akil H., Watson S.J. Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J. Chem. Neuroanat. 1995, 8:283-305.
60. Mansour A., Khachaturian H., Lewis M.E., Akil H., Watson S.J. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J. Neurosci. 1987, 7:2445-2464.
61. Mansour A., Lewis M.E., Khachaturian H., Akil H., Watson S.J. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain. Brain Res. 1986, 399:69-79.
62. Maren S. Long-term potentiation in the amygdala: a mechanism for emotional learning and memory. Trends Neurosci. 1999, 22:561-567.
63. McDonald A.J., Shammah-Lagnado S.J., Shi C., Davis M. Cortical afferents to the extended amygdala. Ann. N.Y. Acad. Sci. 1999, 877:309-338.
64. Mickiewicz A.L., Napier T.C. Repeated exposure to morphine alters surface expression of AMPA receptors in the rat medial prefrontal cortex. Eur. J. Neurosci. 2011, 33:259-265.
65. Moron J.A., Gullapalli S., Taylor C., Gupta A., Gomes I., Devi L.A. Modulation of opiate-related signaling molecules in morphine-dependent conditioned behavior: conditioned place preference to morphine induces CREB phosphorylation. Neuropsychopharmacology 2010, 35:955-966.
66. Narita M., Aoki T., Suzuki T. Molecular evidence for the involvement of NR2B subunit containing N-methyl-D-aspartate receptors in the development of morphine-induced place preference. Neuroscience 2000, 101:601-606.
67. Newpher T.M., Ehlers M.D. Glutamate receptor dynamics in dendritic microdomains. Neuron 2008, 58:472-497.
68. Ostermeier A.M., Schlosser B., Schwender D., Sutor B. Activation of mu- and delta-opioid receptors causes presynaptic inhibition of glutamatergic excitation in neocortical neurons. Anesthesiology 2000, 93:1053-1063.
69. Pacchioni A.M., Kalivas P.W. The role of AMPAR trafficking mediated by neuronal pentraxins in cocaine-induced neuroadaptations. Mol. Cell. Pharmacol. 2009, 1:183-192.
70. Pickel V.M., Colago E.E. Presence of mu-opioid receptors in targets of efferent projections from the central nucleus of the amygdala to the nucleus of the solitary tract. Synapse 1999, 33:141-152.
71. Pitkanen A., Pikkarainen M., Nurminen N., Ylinen A. Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex, and postrhinal cortex in rat. A review. Ann. N. Y. Acad. Sci. 2000, 911:369-391.
72. Pitkanen A., Savander V., LeDoux J.E. Organization of intra-amygdaloid circuitries in the rat: an emerging framework for understanding functions of the amygdala. Trends Neurosci. 1997, 20:517-523.
73. Pollandt S., Liu J., Orozco-Cabal L., Grigoriadis D.E., Vale W.W., Gallagher J.P., Shinnick-Gallagher P. Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA. Eur. J. Neurosci. 2006, 24:1733-1743.
74. Poulin J.F., Chevalier B., Laforest S., Drolet G. Enkephalinergic afferents of the centromedial amygdala in the rat. J. Comp. Neurol. 2006, 496:859-876.
75. Radley J.J., Farb C.R., He Y., Janssen W.G., Rodrigues S.M., Johnson L.R., Hof P.R., LeDoux J.E., Morrison J.H. Distribution of NMDA and AMPA receptor subunits at thalamo-amygdaloid dendritic spines. Brain Res. 2007, 1134:87-94.
76. Rebola N., Srikumar B.N., Mulle C. Activity-dependent synaptic plasticity of NMDA receptors. J. Physiol. 2010, 588:93-99.
77. Reyes B.A., Chavkin C., Van Bockstaele E.J. Agonist-induced internalization of kappa-opioid receptors in noradrenergic neurons of the rat locus coeruleus. J. Chem. Neuroanat. 2010, 40:301-309.
78. Reyes B.A., Fox K., Valentino R.J., Van Bockstaele E.J. Agonist-induced internalization of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus. Eur. J. Neurosci. 2006, 23:2991-2998.
79. Reyes B.A., Valentino R.J., Van Bockstaele E.J. Stress-induced intracellular trafficking of corticotropin-releasing factor receptors in rat locus coeruleus neurons. Endocrinology 2008, 149:122-130.
80. Rezayof A., Golhasani-Keshtan F., Haeri-Rohani A., Zarrindast M.R. Morphine-induced place preference: involvement of the central amygdala NMDA receptors. Brain Res. 2007, 1133:34-41.
81. Ross S., Peselow E. Pharmacotherapy of addictive disorders. Clin. Neuropharmacol. 2009, 32:277-289.
82. Schmidt H.D., Anderson S.M., Famous K.R., Kumaresan V., Pierce R.C. Anatomy and pharmacology of cocaine priming-induced reinstatement of drug seeking. Eur. J. Pharmacol. 2005, 526:65-76.
83. Sepehrizadeh Z., Bahrololoumi Shapourabadi M., Ahmadi S., Hashemi Bozchlou S., Zarrindast M.R., Sahebgharani M. Decreased AMPA GluR2, but not GluR3, mRNA expression in rat amygdala and dorsal hippocampus following morphine-induced behavioural sensitization. Clin. Exp. Pharmacol. Physiol. 2008, 35:1321-1330.
84. Sepehrizadeh Z., Sahebgharani M., Ahmadi S., Shapourabadi M.B., Bozchlou S.H., Zarrindast M.R. Morphine-induced behavioral sensitization increased the mRNA expression of NMDA receptor subunits in the rat amygdala. Pharmacology 2008, 81:333-343.
85. Spruston N., Jonas P., Sakmann B. Dendritic glutamate receptor channels in rat hippocampal CA3 and CA1 pyramidal neurons. J. Physiol. 1995, 482(Pt 2):325-352.
86. Spruston N., Schiller Y., Stuart G., Sakmann B. Activity-dependent action potential invasion and calcium influx into hippocampal CA1 dendrites. Science 1995, 268:297-300.
87. Tanaka H., Grooms S.Y., Bennett M.V., Zukin R.S. The AMPAR subunit GluR2: still front and center-stage. Brain Res. 2000, 886:190-207.
88. Triller A., Choquet D. Surface trafficking of receptors between synaptic and extrasynaptic membranes: and yet they do move!. Trends Neurosci. 2005, 28:133-139.
89. Turner B.H., Herkenham M. Thalamoamygdaloid projections in the rat: a test of the amygdala's role in sensory processing. J. Comp. Neurol. 1991, 313:295-325.
90. Vertes R.P., Hoover W.B. Projections of the paraventricular and paratenial nuclei of the dorsal midline thalamus in the rat. J. Comp. Neurol. 2008, 508:212-237.
91. Wang H., Gracy K.N., Pickel V.M. Mu-opioid and NMDA-type glutamate receptors are often colocalized in spiny neurons within patches of the caudate-putamen nucleus. J. Comp. Neurol. 1999, 412:132-146.
92. Watanabe T., Nakagawa T., Yamamoto R., Maeda A., Minami M., Satoh M. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Jpn J. Pharmacol. 2002, 88:399-406.
93. Yang T.T., Hung C.F., Lee Y.J., Su M.J., Wang S.J. Morphine inhibits glutamate exocytosis from rat cerebral cortex nerve terminals (synaptosomes) by reducing Ca2+ influx. Synapse 2004, 51:83-90.
94. Zhu W., Bie B., Pan Z.Z. Involvement of non-NMDA glutamate receptors in central amygdala in synaptic actions of ethanol and ethanol-induced reward behavior. J. Neurosci. 2007, 27:289-298.
95. Zhu W., Pan Z.Z. Synaptic properties and postsynaptic opioid effects in rat central amygdala neurons. Neuroscience 2004, 127:871-879.
96. Zhu W., Pan Z.Z. Mu-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons. Neuroscience 2005, 133:97-103.